Production (Stage)
Core Scientific, Inc.
CORZ
$10.68
-$0.15-1.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -57.91% | -49.51% | -8.82% | 1.77% | 29.62% |
| Total Other Revenue | -55.20% | -28.77% | -17.96% | 14.07% | 52.98% |
| Total Revenue | -55.64% | -33.12% | -15.54% | 11.18% | 48.60% |
| Cost of Revenue | -29.84% | -16.34% | -6.98% | 10.27% | 14.37% |
| Gross Profit | -89.42% | -76.94% | -69.67% | 13.40% | 144.32% |
| SG&A Expenses | 137.03% | 52.46% | 72.45% | 26.79% | -25.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2,068.32% | -79.49% | -35.22% | 472.96% | -6,687.50% |
| Total Operating Expenses | 3.46% | -1.46% | 9.19% | 14.94% | 4.40% |
| Operating Income | -169.52% | -837.24% | -247.83% | -34.55% | 705.91% |
| Income Before Tax | 175.44% | -35.73% | -1,009.20% | -8,713.40% | 74,359.51% |
| Income Tax Expenses | -0.49% | 11.61% | 17.54% | 11.63% | 98.08% |
| Earnings from Continuing Operations | 175.61% | -35.69% | -1,006.45% | -8,592.18% | 54,401.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 175.61% | -35.69% | -1,006.45% | -8,592.18% | 54,401.80% |
| EBIT | -169.52% | -837.24% | -247.83% | -34.55% | 705.91% |
| EBITDA | -125.33% | -137.16% | -195.93% | 18.83% | 225.90% |
| EPS Basic | 57.66% | -18.77% | -991.26% | -18,229.67% | 91,330.00% |
| Normalized Basic EPS | 327.74% | -313.23% | -4,544.98% | -17,936.71% | 1,438.86% |
| EPS Diluted | 61.21% | -17.78% | -967.45% | -18,233.33% | 77,640.00% |
| Normalized Diluted EPS | 354.02% | -313.23% | -4,544.98% | -17,936.71% | 1,157.71% |
| Average Basic Shares Outstanding | 36.47% | -20.50% | -23.53% | -52.50% | -38.48% |
| Average Diluted Shares Outstanding | 28.59% | -20.50% | -23.53% | -52.50% | -24.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |